Stock ABB AB-BIOTICS, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

All News AB-Biotics, S.A.

Equities

ABB

ES0109659013

End-of-day quote BME
Other stock markets
 		5-day change 1st Jan Change
- EUR -.--% Intraday chart for AB-Biotics, S.A. -.--% -.--%
2022 AB-Biotics, S.A. acquired Alifarm S.A. for EUR 3.5 million. CI
2019 Kaneka Europe Holding Company N.V. completed the acquisition of 18.21% stake in AB-Biotics, S.A. CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
AB-Biotics, S.A. acquired Alifarm S.A. for EUR 3.5 million.
CI
Kaneka Europe Holding Company N.V. completed the acquisition of 18.21% stake in AB-Biotics, S.A.
CI
Kaneka Europe Holding Company N.V. made an offer to acquire remaining 33.67% stake in AB-Biotics, S.A. for €21.2 million.
CI
Kaneka Corporation has completed the voluntary offer to acquire an additional 26.57% stake in AB-Biotics, S.A. for €16.7 million.
CI
Kaneka Corporation made a voluntary public offer to acquire the remaining 60.24% stake in AB-Biotics, S.A. for €37.9 million.
CI
Ab-Biotics Sa Reports Earnings Results for the Full Year Ended December 31, 2018
CI
Kaneka Corporation Concludes License Agreement with AB-Biotics for Production and Sales of its Probiotics Products
CI
Kaneka Corporation completed the acquisition of 26.87% stake in AB-Biotics, S.A. from Corporacion Ivamosa, Gestion Y Administracion Mobiliaria, S.A., Capital MAB, FCR fund of Institut Català de Finances Capital, SGEIC, S.A. and Buanaventura Guamis.
CI
Kaneka Americas Holding Inc. enters into Licensing Agreement with AB-Biotics, S.A
CI
Kaneka Corporation signed an agreement to acquire 26.87% stake in AB-Biotics, S.A. from Corporacion Ivamosa, Gestion Y Administracion Mobiliaria, S.A., Capital MAB, FCR fund of Institut Català de Finances Capital, SGEIC, S.A. and Buanaventura Guamis.
CI
Corporacion Ivamosa and Gestion Y Administracion Mobiliaria, S.A. acquired 10% stake in AB-Biotics, S.A..
CI
Frutarom Industries Ltd. acquired AB-Fortis from AB-Biotics, S.A..
CI
AB-Biotics SA announced a financing transaction
CI
AB-Biotics Agrees Distribution Deal with Abbott for I3.1 Probiotic in Spain
CI
DuPont Nutrition & Health and AB-Biotics Announce Agreement on Probiotic for Cardiovascular Health
CI
AB-Biotics Provides Earnings Guidance for the Full Year of 2013
CI
AB-Biotics SA sold Quantum Experimental S.L.
CI
AB-Biotics and Scienta Farma Sign Distribution Agreement to Market Genetic Test Neurofarmagen in Mexico
CI
AB-Biotics SA announced that it expects to receive €1.08 million in funding.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABB Stock
  4. News AB-Biotics, S.A.